FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Schteingart

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Maria Fleseriu; Coleman Gross; Mark E Molitch; David E Schteingart; T Brooks Vaughan; Beverly M K Biller
A New Therapeutic Approach in the Medical Treatment of Cushing's Syndrome: Glucocorticoid Receptor Blockade with Mifepristone.
David E Schteingart
Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotide.
David E Schteingart; Joseph E Sinsheimer; Ricardo S Benitez; Dominic F Homan; Timothy D Johnson; Raymond E Counsell
Structural requirements for mitotane activity: development of analogs for treatment of adrenal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Schteingart (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maria Fleseriu; Coleman Gross; Mark E Molitch; David E Schteingart; T Brooks Vaughan; Beverly M K Biller
A New Therapeutic Approach in the Medical Treatment of Cushing's Syndrome: Glucocorticoid Receptor Blockade with Mifepristone.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2013;19(2):313-26.
2012: David E Schteingart
Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotide.
Expert opinion on emerging drugs 2012;17(3):279-83.
2012: David E Schteingart; Joseph E Sinsheimer; Ricardo S Benitez; Dominic F Homan; Timothy D Johnson; Raymond E Counsell
Structural requirements for mitotane activity: development of analogs for treatment of adrenal cancer.
Anticancer research 2012;32(7):2711-20.
2012: Martin Fassnacht; Tito Fojo; Hans Gelderblom; Harm Haak; Stefanie Hahner; Ilse Hermsen; Barbara Jarzab; Werner Kenn; Matthias Kroiss; André Lacroix; Sophie Leboulleux; Franco Mantero; Hans-Helge Müller; Marcus Quinkler; Carmen Schade-Brittinger; Martin Schlumberger; David E Schteingart; Monica Sender; Britt Skogseid; Halfdan Sorbye; Paola Sperone; Vinzenz Stepan; Anders Sundin; Antoine Tabarin; Massimo Terzolo; David J Torpy; Dirk Weismann; Staffan Welin; Holger S Willenberg; Hanneke Wilmink; Bruno Allolio; Wiebke Arlt; Eric Baudin; Alfredo Berruti; Felix Beuschlein; Christelle de la Fouchardière; Maureen Edgerly
Combination chemotherapy in advanced adrenocortical carcinoma.
The New England journal of medicine 2012;366(23):2189-97.
2012: Matthew H Kulke; Pamela L Kunz; Boris W Kuvshinoff; Jeffrey F Moley; Venu G Pillarisetty; Leonard Saltz; David E Schteingart; Manisha H Shah; Stephen Shibata; Jonathan R Strosberg; Jean-Nicolas Vauthey; Rebekah White; James C Yao; Al B Benson; Emily Bergsland; Jordan D Berlin; Lawrence S Blaszkowsky; Michael A Choti; Orlo H Clark; Gerard M Doherty; Mary A Dwyer; James Eason; Lyska Emerson; Paul F Engstrom; Deborah A Freedman-Cass; Whitney S Goldner; Martin J Heslin; Fouad Kandeel
Neuroendocrine tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(6):724-64.
2012: David E Schteingart
The clinical spectrum of adrenocortical hyperplasia.
Current opinion in endocrinology, diabetes, and obesity 2012;19(3):176-82.
2012: Maria Fleseriu; Coleman Gross; Mark E Molitch; David E Schteingart; Beverly M K Biller; James W Findling
Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.
The Journal of clinical endocrinology and metabolism 2012;97(6):2039-49.
2012: Scott A Langenecker; Hadia M Leon; Douglas C Noll; Michael-Paul Schallmo; David E Schteingart; Emily M Briceño; Bruno Giordani; Leslie M Guidotti Breting; Sara L Weisenbach; Jon K Zubieta; monica starkman
Impact of chronic hypercortisolemia on affective processing.
Neuropharmacology 2012;62(1):217-25.
2011: Irina Y Dobrosotskaya; Gary Hammer; Katherine Maturen; David E Schteingart; Francis P Worden
Mebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinoma.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2011;17(3):e59-62.
2010: David E Schteingart; Ricardo Benitez; Carol R Bradford; Ajita Narayan; Shaomeng Wang
Expression of anti-apoptosis genes determines the response of adrenal cancer to apoptosis-inducing chemotherapy.
Anticancer research 2010;30(12):4805-9.
2010: Doris McGartland Rubio; Ellie E Schoenbaum; Linda S Lee; David E Schteingart; Paul R Marantz; Karl E Anderson; Lauren Dewey Platt; Adriana Baez; Karin Esposito
Defining translational research: implications for training.
Academic medicine : journal of the Association of American Medical Colleges 2010;85(3):470-5.
2010: Paul Haluska; Frank Worden; David Olmos; Donghua Yin; David E Schteingart; Gretchen N Batzel; M Luisa Paccagnella; Johann S de Bono; Antonio Gualberto; Gary Hammer
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma.
Cancer chemotherapy and pharmacology 2010;65(4):765-73.
2009: David E Schteingart
Drugs in the medical treatment of Cushing's syndrome.
Expert opinion on emerging drugs 2009;14(4):661-71.
2009: Israel Hodish; Thomas J Giordano; monica starkman; David E Schteingart
Location of ectopic adrenocortical hormone-secreting tumors causing Cushing's syndrome in the paranasal sinuses.
Head & neck 2009;31(5):699-706.
2007: monica starkman; Bruno Giordani; Stephen S Gebarski; David E Schteingart
Improvement in mood and ideation associated with increase in right caudate volume.
Journal of affective disorders 2007;101(1-3):139-47.
2007: David E Schteingart
Adjuvant mitotane therapy of adrenal cancer - use and controversy.
The New England journal of medicine 2007;356(23):2415-8.
2007: Julie N Hook; Bruno Giordani; David E Schteingart; Kenneth E Guire; Jodie Giles; Kelley Ryan; Stephen S Gebarski; Scott A Langenecker; monica starkman
Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease.
Journal of the International Neuropsychological Society : JINS 2007;13(1):21-9.
2006: Gavin C Mackie; Barry L Shulkin; Raul C Ribeiro; Francis P Worden; Paul G Gauger; Rajen J Mody; Len P Connolly; Ghada Kunter; Carlos Rodriguez-Galindo; Jerold W Wallis; Craig A Hurwitz; David E Schteingart
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.
The Journal of clinical endocrinology and metabolism 2006;91(7):2665-71.
2006: Orlo H Clark; Jaffer A Ajani; Al B Benson; David Byrd; Gerard M Doherty; Paul F Engstrom; David S Ettinger; John F Gibbs; Martin J Heslin; Fouad Kandeel; Anne Kessinger; Matthew H Kulke; Larry K Kvols; Albert A Nemcek; John Olson; Thomas W Ratliff; Leonard B Saltz; David E Schteingart; Manisha H Shah; Stephen Shibata
Neuroendocrine tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(2):102-38.
2005: David E Schteingart; Gerard M Doherty; Paul G Gauger; Thomas J Giordano; Gary Hammer; Melvyn Korobkin; Francis P Worden
Management of patients with adrenal cancer: recommendations of an international consensus conference.
Endocrine-related cancer 2005;12(3):667-80.
2005: David E Schteingart
The 50th anniversary of the identification of primary aldosteronism: a retrospective of the work of Jerome W. Conn.
The Journal of laboratory and clinical medicine 2005;145(1):12-6.
2003: monica starkman; Bruno Giordani; Stephen S Gebarski; David E Schteingart
Improvement in learning associated with increase in hippocampal formation volume.
Biological psychiatry 2003;53(3):233-8.
2003: William F Chandler; Ariel L Barkan; David E Schteingart
Management options for persistent functional tumors.
Neurosurgery clinics of North America 2003;14(1):139-45, viii.
2002: Liselle Douyon; David E Schteingart
Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion.
Endocrinology and metabolism clinics of North America 2002;31(1):173-89.
2001: monica starkman; Bruno Giordani; Stanley Berent; M Anthony Schork; David E Schteingart
Elevated cortisol levels in Cushing's disease are associated with cognitive decrements.
Psychosomatic medicine 2001;63(6):985-93.
2001: David E Schteingart
Current perspective in the diagnosis and treatment of adrenocortical carcinoma.
Reviews in endocrine & metabolic disorders 2001;2(3):323-33.
2001: David E Schteingart; Thomas J Giordano; R S Benitez; M D Burdick; monica starkman; Douglas Arenberg; Robert M Strieter
Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome.
The Journal of clinical endocrinology and metabolism 2001;86(8):3968-74.
2001: Constantine Straturis; S E Taymans; David E Schteingart; B R Haddad
Segmental uniparental isodisomy (UPD) for 2p16 without clinical symptoms: implications for UPD and other genetic studies of chromosome 2.
Journal of medical genetics 2001;38(2):106-9.
2000: David E Schteingart
Conventional and novel strategies in the treatment of adrenocortical cancer.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2000;33(10):1197-200.
2000: David E Schteingart
Management approaches to adrenal incidentalomas. A view from Ann Arbor, Michigan.
Endocrinology and metabolism clinics of North America 2000;29(1):127-39, ix-x.
1999: monica starkman; Bruno Giordani; Stephen S Gebarski; Stanley Berent; M Anthony Schork; David E Schteingart
Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease.
Biological psychiatry 1999;46(12):1595-602.
1999: ZI Assi; Nicolaas I Bohnen; David E Schteingart; Milton D Gross; Brahm Shapiro
Testicular I-131 6beta-iodomethyl-19-norcholesterol uptake in a patient with adrenogenital syndrome.
Clinical nuclear medicine 1999;24(6):464.
1997: W Cai; Raymond E Counsell; David E Schteingart; J E Sinsheimer; A D Vaz; LL Wotring
Adrenal proteins bound by a reactive intermediate of mitotane.
Cancer chemotherapy and pharmacology 1997;39(6):537-40.
1996: Z Kronfol; monica starkman; David E Schteingart; V Singh; Q Zhang; E Hill
Immune regulation in Cushing's syndrome: relationship to hypothalamic-pituitary-adrenal axis hormones.
Psychoneuroendocrinology 1996;21(7):599-608.
1996: J E Sinsheimer; Raymond E Counsell; W Cai; R Gopalaswamy; P Mahalakshmi; M L Piñeiro-Sánchez; N Ruangwises; David E Schteingart
Gas chromatographic-electron capture determination of 2,4'-dichlorodiphenylacetic acid from in-vitro adrenal transformations of mitotane and its analogs.
Journal of pharmaceutical and biomedical analysis 1996;14(7):861-6.
1995: Oliver G Cameron; monica starkman; David E Schteingart
The effect of elevated systemic cortisol levels on plasma catecholamines in Cushing's syndrome patients with and without depressed mood.
Journal of psychiatric research 1995;29(5):347-60.
1995: W Cai; R Benitez; Raymond E Counsell; T Djanegara; David E Schteingart; J E Sinsheimer; LL Wotring
Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers.
Biochemical pharmacology 1995;49(10):1483-9.
1995: W Cai; Raymond E Counsell; T Djanegara; David E Schteingart; J E Sinsheimer; LL Wotring
Metabolic activation and binding of mitotane in adrenal cortex homogenates.
Journal of pharmaceutical sciences 1995;84(2):134-8.
1994: Milton D Gross; Brahm Shapiro; Isaac R Francis; G M Glazer; R L Bree; M A Arcomano; David E Schteingart; M K McLeod; J A Sanfield; Norman W Thompson
Scintigraphic evaluation of clinically silent adrenal masses.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(7):1145-52.
1993: Adrian S Dobs; P S Sarma; David E Schteingart
Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Metabolism: clinical and experimental 1993;42(9):1146-52.
1993: David E Schteingart; J E Sinsheimer; Raymond E Counsell; G D Abrams; N McClellan; T Djanegara; J Hines; N Ruangwises; R Benitez; LL Wotring
Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma.
Cancer chemotherapy and pharmacology 1993;31(6):459-66.
1992: J E Shipley; David E Schteingart; Rajiv Tandon; monica starkman
Sleep architecture and sleep apnea in patients with Cushing's disease.
Sleep 1992;15(6):514-8.
1992: monica starkman; Stephen S Gebarski; Stanley Berent; David E Schteingart
Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome.
Biological psychiatry 1992;32(9):756-65.
1992: J L Pasieka; M K McLeod; Norman W Thompson; Milton D Gross; David E Schteingart
Adrenal scintigraphy of well-differentiated (functioning) adrenocortical carcinomas: potential surgical pitfalls.
Surgery 1992;112(5):884-90.
1992: monica starkman; David E Schteingart; M A Schork
Discordant changes in plasma ACTH and beta-lipotropin/beta-endorphin levels in Cushing's disease patients with depression.
Psychoneuroendocrinology 1992;17(6):619-26.
1992: J E Shipley; David E Schteingart; Rajiv Tandon; A C Pande; Leon Grunhaus; R F Haskett; monica starkman
EEG sleep in Cushing's disease and Cushing's syndrome: comparison with patients with major depressive disorder.
Biological psychiatry 1992;32(2):146-55.
1992: David E Schteingart
Effectiveness of phenylpropanolamine in the management of moderate obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1992;16(7):487-93.
1991: David E Schteingart
Ectopic secretion of peptides of the proopiomelanocortin family.
Endocrinology and metabolism clinics of North America 1991;20(3):453-71.
1991: R M Lampman; David E Schteingart
Effects of exercise training on glucose control, lipid metabolism, and insulin sensitivity in hypertriglyceridemia and non-insulin dependent diabetes mellitus.
Medicine and science in sports and exercise 1991;23(6):703-12.
1989: David E Schteingart
Cushing's syndrome.
Endocrinology and metabolism clinics of North America 1989;18(2):311-38.
1988: Lorraine M Fig; Milton D Gross; Brahm Shapiro; D A Ehrmann; J E Freitas; David E Schteingart; G M Glazer; Isaac R Francis
Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
Annals of internal medicine 1988;109(7):547-53.
1988: James M Mountz; Milton D Gross; Brahm Shapiro; Ariel L Barkan; M C Woodbury; David E Schteingart; J W Ayers
Scintigraphic localization of ovarian dysfunction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(10):1644-50.
1987: David E Schteingart; William F Chandler; R V Lloyd; G Ibarra-Perez
Cushing's syndrome caused by an ectopic pituitary adenoma.
Neurosurgery 1987;21(2):223-7.
1987: A Funakoshi; David E Schteingart; A I Vinik
Effect of insulin on motilin release in man.
The Tohoku journal of experimental medicine 1987;152(3):247-51.
1987: R M Lampman; David E Schteingart; J T Santinga; P J Savage; C R Hydrick; D R Bassett; W D Block
The influence of physical training on glucose tolerance, insulin sensitivity, and lipid and lipoprotein concentrations in middle-aged hypertriglyceridaemic, carbohydrate intolerant men.
Diabetologia 1987;30(6):380-5.
1987: William F Chandler; David E Schteingart; R V Lloyd; Paul E McKeever; G Ibarra-Perez
Surgical treatment of Cushing's disease.
Journal of neurosurgery 1987;66(2):204-12.
1986: monica starkman; David E Schteingart; M A Schork
Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome.
Psychiatry research 1986;19(3):177-88.
1986: David E Schteingart; R V Lloyd; Huda Akil; William F Chandler; G Ibarra-Perez; S G Rosen; R Ogletree
Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion.
The Journal of clinical endocrinology and metabolism 1986;63(3):770-5.
1986: R V Lloyd; William F Chandler; Paul E McKeever; David E Schteingart
The spectrum of ACTH-producing pituitary lesions.
The American journal of surgical pathology 1986;10(9):618-26.
1986: monica starkman; David E Schteingart; M A Schork
Correlation of bedside cognitive and neuropsychological tests in patients with Cushing's syndrome.
Psychosomatics 1986;27(7):508-11.
1986: A I Vinik; S Seino; A Funakoshi; J Schwartz; M Matsumoto; David E Schteingart; Z Z Fu; S T Tsai
Familial hyperinsulinemia associated with secretion of an abnormal insulin, and coexistence of insulin resistance in the propositus.
The Journal of clinical endocrinology and metabolism 1986;62(4):645-52.
1986: R M Lampman; David E Schteingart; M L Foss
Exercise as a partial therapy for the extremely obese.
Medicine and science in sports and exercise 1986;18(1):19-24.
1986: William F Chandler; David E Schteingart
Controversies in the management of Cushing's disease.
Clinical neurosurgery 1986;33():553-62.
1984: D B DeStephano; R V Lloyd; David E Schteingart
Cushing's syndrome produced by a bronchial carcinoid tumor.
Human pathology 1984;15(9):890-2.
1984: Milton D Gross; Brahm Shapiro; J E Freitas; J Ayers; D P Swanson; M C Woodbury; David E Schteingart; W H Beierwaltes
The relationship of I-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal cortical uptake to indices of androgen secretion in women with hyperandrogenism.
Clinical nuclear medicine 1984;9(5):264-70.
1982: David E Schteingart; A Motazedi; R A Noonan; Norman W Thompson
Treatment of adrenal carcinomas.
Archives of surgery (Chicago, Ill. : 1960) 1982;117(9):1142-6.
1981: David E Schteingart
The medical management of obesity.
Michigan medicine 1981;80(17):322-4.
1981: David E Schteingart; J E Seabold; Milton D Gross; D P Swanson
Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.
The Journal of clinical endocrinology and metabolism 1981;52(6):1156-61.
1981: Milton D Gross; T W Valk; J E Freitas; D P Swanson; David E Schteingart; W H Beierwaltes
The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.
The Journal of clinical endocrinology and metabolism 1981;52(6):1062-6.
1981: monica starkman; David E Schteingart; M A Schork
Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels.
Psychosomatic medicine 1981;43(1):3-18.
1981: monica starkman; David E Schteingart
Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.
Archives of internal medicine 1981;141(2):215-9.
1981: Milton D Gross; J E Freitas; D P Swanson; M C Woodbury; David E Schteingart; W H Beierwaltes
Dexamethasone-suppression adrenal scintigraphy in hyperandrogenism: concise communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1981;22(1):12-7.
1981: J Tulin-Silver; David E Schteingart; K P Mathews
Effect of theophylline on cortisol secretion.
The Journal of allergy and clinical immunology 1981;67(1):45-50.
1980: T B Whelan; David E Schteingart; monica starkman; A Smith
Neuropsychological deficits in Cushing's syndrome.
The Journal of nervous and mental disease 1980;168(12):753-7.
1980: T W Valk; Milton D Gross; J E Freitas; D P Swanson; David E Schteingart; W H Beierwaltes
The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(11):1069-72.
1980: David E Schteingart; A K McKenzie
Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
The Journal of clinical endocrinology and metabolism 1980;51(5):1195-8.
1980: David E Schteingart; H S Tsao; C I Taylor; A McKenzie; R Victoria; B A Therrien
Sustained remission of Cushing's disease with mitotane and pituitary irradiation.
Annals of internal medicine 1980;92(5):613-9.
1980: David E Schteingart; H S Tsao
Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma.
The Journal of clinical endocrinology and metabolism 1980;50(5):961-6.
1980: David E Schteingart
Suppression of cortisol secretion by human growth hormone.
The Journal of clinical endocrinology and metabolism 1980;50(4):721-5.
1980: M L Foss; R M Lampman; David E Schteingart
Extremely obese patients: improvements in exercise tolerance with physical training and weight loss.
Archives of physical medicine and rehabilitation 1980;61(3):119-24.
1979: David E Schteingart; A K McKenzie; R S Victoria; H S Tsao
Suppression of insulin secretion by protein deprivation in obesity.
Metabolism: clinical and experimental 1979;28(9):943-9.
1979: S S Stoffer; R Weitzman; David E Schteingart
Adrenalectomy and Cushing's disease.
Archives of surgery (Chicago, Ill. : 1960) 1979;114(8):980.
1979: David E Schteingart; M C Woodbury; H S Tsao; A K McKenzie
Virilizing syndrome associated with an adrenal cortical adenoma secreting predominantly testosterone.
The American journal of medicine 1979;67(1):140-6.
1979: David E Schteingart; A K McKenzie; R S Victoria; H S Tsao
Suppression of insulin secretion by protein deprivation in obesity.
Advances in experimental medicine and biology 1979;119():125-35.
1978: R P Tucker; H E Weinstein; David E Schteingart; monica starkman
EEG changes and serum cortisol levels in cushing's syndrome.
Clinical EEG (electroencephalography) 1978;9(1):32-7.
1976: M L Foss; R M Lampman; David E Schteingart
Physical training program for rehabilitating extremely obese patients.
Archives of physical medicine and rehabilitation 1976;57(9):425-9.
1975: M L Foss; R M Lampman; E Watt; David E Schteingart
Initial work tolerance of extremely obese patients.
Archives of physical medicine and rehabilitation 1975;56(2):63-7.
1974: V D Reif; J E Sinsheimer; J C Ward; David E Schteingart
Aromatic hydroxylation and alkyl oxidation in metabolism of mitotane (o,p'-DDD) in humans.
Journal of pharmaceutical sciences 1974;63(11):1730-6.
1974: D C Moses; David E Schteingart; M F Sturman; W H Beierwaltes; R D Ice
Efficacy of radiocholesterol imaging of the adrenal glands in Cushing's syndrome.
Surgery, gynecology & obstetrics 1974;139(2):201-4.
1974: K R Herwig; David E Schteingart
Successful removal of adrenal remnant localized by 131-I-19-iodocholesterol.
The Journal of urology 1974;111(6):713-4.
1973: K R Herwig; J W Conn; David E Schteingart; W H Beierwaltes
Localization of adrenal tumors by photoscanning.
The Journal of urology 1973;109(1):2-4.
1972: David E Schteingart; J W Conn; L M Lieberman; W H Beierwaltes
Persistent or recurrent Cushing's syndrome after "total" adrenalectomy: adrenal photoscanning for residual tissue.
Archives of internal medicine 1972;130(3):384-7.
1972: David E Schteingart; J W Conn; D N Orth; T S Harrison; J E Fox; J J Bookstein
Secretion of ACTH and -MSH by an adrenal medullary paraganglioma.
The Journal of clinical endocrinology and metabolism 1972;34(4):676-83.
1972: J E Sinsheimer; J Guilford; L J Bobrin; David E Schteingart
Identification of o,p'-dichlorodiphenyl acetic acid as a urinary metabolite of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane.
Journal of pharmaceutical sciences 1972;61(2):314-6.
1968: David E Schteingart; H A Oberman; Bruce Friedman; J W Conn
Adrenal cortical neoplasms producing cushing's syndrome. A clinicopathologic study.
Cancer 1968;22(5):1005-13.
1967: David E Schteingart; J W Conn
Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
The Journal of clinical endocrinology and metabolism 1967;27(12):1657-66.
1967: S R Reuter; A J Blair; David E Schteingart; J J Bookstein
Adrenal venography.
Radiology 1967;89(5):805-14.
1967: David E Schteingart
Adrenal function and disease in pregnancy.
Clinical obstetrics and gynecology 1967;10(1):88-105.
1966: David E Schteingart; R Cash; J W Conn
Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome.
JAMA : the journal of the American Medical Association 1966;198(9):1007-10.
1966: David E Schteingart; J W Conn
[Characteristics of the adrenal cortex hyperfunction in obesity].
Prensa médica argentina 1966;53(9):978-90.
1965: David E Schteingart; J W Conn
Characteristics of the increased adrenocortical function observed in many obese patients.
Annals of the New York Academy of Sciences 1965;131(1):388-403.
1964: David E Schteingart; R Y GREGERMAN; J W CONN
[COMPARISON OF THE CHARACTERISTICS OF ADRENOCORTICAL HYPERFUNCTION IN SIMPLE OBESITY AND IN CUSHING'S SYNDROME].
El Día médico 1964;36():306-7.
1963: A P CRAIG; David E Schteingart; M W SHAW
GONADAL DYSGENESIS WITH XUXX MOSAICISM AND A POSITIVE SEX CHROMATIN PATTERN.
The Journal of clinical endocrinology and metabolism 1963;23():752-8.
1963: David E Schteingart; R I GREGERMAN; J W CONN
A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing's syndrome.
Metabolism: clinical and experimental 1963;12():484-97.
1961: SS Fajans; J M SCHNEIDER; David E Schteingart; J W CONN
The diagnostic value of sodium tolbutamide in hypoglycemic states.
The Journal of clinical endocrinology and metabolism 1961;21():371-86.
1960: David E Schteingart; M PERLMUTTER; M NUMEROFF
Effect of diuretics upon the serum protein bound iodine and the thyroidal uptake of radioactive iodine.
The American journal of the medical sciences 1960;239():571-7.
1957: C GUERRA; A KAPLAN; A LEMBERG; David E Schteingart; A SINGERMAN
[Acute poisoning caused by methyl chloride; refrigerating gas].
Prensa médica argentina 1957;44(22):1671-6.